Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 4 of 4 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/03/22
End: 09/09/22
Due: 09/09/23
Phase: N/A
Priority: Normal
Start: 02/27/23
End: 02/12/24
Due: 02/12/25
Phase: N/A
Priority: Normal
Start: 04/12/19
End: 08/08/19
Due: 08/08/20
Phase: N/A
Priority: Normal
Start: 12/02/20
End: 06/11/21
Due: 06/11/22
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| AT247, NovoLog® and Fiasp® Administered Via Continuous Subcutaneous Infusion in Glucose Clamp Study | NCT05184868 | Arecor Limited | user2@example.com | None | 2022-01-03 | 2022-09-09 | 2023-09-09 | - | - | 2025-07-14 |
| AT278, NovoRapid® and Humulin® R (U500) in Glucose Clamp Study | NCT05754424 | Arecor Limited | user2@example.com | None | 2023-02-27 | 2024-02-12 | 2025-02-12 | - | - | 2025-07-14 |
| AT247, NovoRapid® and Fiasp® in Glucose Clamp Study | NCT03959514 | Arecor Limited | user2@example.com | None | 2019-04-12 | 2019-08-08 | 2020-08-08 | - | - | 2025-07-14 |
| AT278 and NovoRapid® in Glucose Clamp Study | NCT04660305 | Arecor Limited | user2@example.com | None | 2020-12-02 | 2021-06-11 | 2022-06-11 | - | - | 2025-07-14 |